Stock listing
NASDAQ:GEVA Synageva BioPharma Corp Stock
Follow Synageva BioPharma Corp into a list and get an email when it puts out news.
Last close · NASDAQ:GEVA
$238.60 USD
Close on Jun 22, 2015 · No longer trades
- Lowest – highest close
- $4.30 – $238.60 USDSince Jan 4, 1999 · lowest Jan 20, 2009 · highest Jun 22, 2015
Delisted NASDAQ:GEVA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:GEVA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Synageva BioPharma Corp on 6ix
- Decks
- 6 decks · latest Jun 5, 2015
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (June 2015) | Merger or acquisition | 31 slides | Jun 5, 2015 |
| Merger or Acquisition (May 2015) | Merger or acquisition | 30 slides | May 11, 2015 |
| Merger or Acquisition (May 2015) | Merger or acquisition | 20 slides | May 6, 2015 |
| Trimeris — Merger or Acquisition (September 2011) | Merger or acquisition | 32 slides | Sep 7, 2011 |
| Trimeris — Merger or Acquisition (July 2011) | Merger or acquisition | 19 slides | Jul 27, 2011 |
| Trimeris — Merger or Acquisition (July 2011) | Merger or acquisition | 32 slides | Jul 20, 2011 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Felix Baker Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past) | Director · Aug 14, 2007 – Jun 22, 2015 · Past |
| Julian Baker Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Apr 6, 2010 – Jun 19, 2012 · Past); Seagen Inc (Director · Jun 9, 2006 – Dec 14, 2023 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past) | Director · Apr 25, 2006 – Jun 22, 2015 · Past |
| Mark Alan Goldberg Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past) | EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past |
| Stephen Davis Other companies: Bellicum Pharmaceuticals Inc (Director · Jul 13, 2015 – Jan 3, 2023 · Past); ACADIA Pharmaceuticals Inc. (CEO, Director · Jul 15, 2014 – Aug 16, 2024 · Past); Furiex Pharmaceuticals Inc (Director · May 24, 2013 – Jul 2, 2014 · Past); Ardea Biosciences Inc (EVP & COO · Apr 6, 2010 – Jun 19, 2012 · Past); Heron Therapeutics, Inc. (Director · Feb 17, 2010 – Dec 16, 2022 · Past); Neurogen Corp (President, CEO, Director · Dec 15, 2006 – Jul 25, 2008 · Past) | Director · Jun 27, 2007 – Jun 22, 2015 · Past |
| Carsten Boess Other companies: Atrium Therapeutics, Inc. (Director · Since at least Nov 10, 2025); Avidity Biosciences, Inc (Director · Since at least Jun 11, 2020); Rocket Pharmaceuticals, Inc. (Director · Since at least Jan 11, 2016); Orchestra BioMed Holdings, Inc. (Director · Aug 3, 2020 – Aug 3, 2020 · Past); Insulet Corporation (Vice President, International · May 14, 2007 – Apr 25, 2011 · Past) | SVP, Chief Financial Officer · Nov 2, 2011 – Jun 22, 2015 · Past |
| Arthur Bruce Cohen Other companies: CareView Communications, Inc. (Director · Apr 21, 2011 – May 24, 2023 · Past) | Director · Feb 8, 2008 – Jul 23, 2009 · Past |
| Gary Cook Other companies: Louisiana-Pacific Corporation (Director · Jun 26, 2006 – May 17, 2020 · Past) | Director · Aug 9, 2006 – Aug 9, 2006 · Past |
| Michael Glynn Other companies: Pacific Biosciences of California, Inc. (Chief Commercial Officer · Oct 4, 2011 – Feb 15, 2012 · Past) | SVP, Global Commercial Ops. · Oct 30, 2012 – Jun 6, 2013 · Past |
| Steven D Skolsky Other companies: Novan Inc (Director · Mar 1, 2021 – Jun 6, 2023 · Past) | Chief Executive Officer, Director · Jan 3, 2006 – Oct 2, 2006 · Past |
| Glen Williams | SVP, Technical Operations · Sep 24, 2012 – Jun 22, 2015 · Past |
All 11 people
| Person | Seat |
|---|---|
| Hybrid Offshore HealthCor | Director · Jun 26, 2008 – Jul 23, 2009 · Past |
Log in to ask 6ix AI your own questions about Synageva BioPharma Corp.